PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Health Security, Expert Microbiology Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.\', \'Meilahti Infectious Diseases and Vaccination Research Center, MeiVac, Department of Infectious Diseases, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.\', \'Department of Virology, University of Helsinki, Helsinki, Finland.\', \'Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland.\', \'Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland.\', \'Infection and Immunity, Institute of Biomedicine, University of Turku, Turku, Finland.\', \'Department of Health Security, Infectious Disease Control and Vaccinations Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.\', \'Clinical Microbiology, Turku University Hospital, Turku, Finland.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1128/Spectrum.01131-21
?:doi
?:hasPublicationType
?:journal
  • Microbiology spectrum
is ?:pmid of
?:pmid
?:pmid
  • 34787485
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.814
?:rankingScore_hIndex
  • 21
?:title
  • A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all